{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:43:42Z","timestamp":1788335022298,"version":"build-2803163510"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR;PJT155933"],"award-info":[{"award-number":["CIHR;PJT155933"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["ID#1188460"],"award-info":[{"award-number":["ID#1188460"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system, whereby clinical disease activity is primarily monitored by magnetic resonance imaging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Given the limitations associated with implementing and acquiring novel and emerging imaging biomarkers in routine clinical practice, the discovery of biofluid biomarkers may offer a more simple and cost-effective measure that would improve accessibility, standardization, and patient care. Extracellular vesicles (EVs) are nanoparticles secreted from cells under both homeostatic and pathological states, and have been recently investigated as biomarkers in MS. The objectives of this study were to longitudinally measure levels of specific immune cell-derived EVs in MS and provide evidence that EV sub-populations may serve as biomarkers of disease activity, axonal injury, and\/or clinical disability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our results demonstrate that the rate of clinical disability in MS negatively correlates with changes in circulating CD3+ EVs within the plasma. Additionally, numbers of CD4+ EVs decrease in individuals with increasing pNfL levels overtime whereby the magnitude of the pNfL increase negatively correlates with changes in plasma CD4+ and CD8+ EVs. Finally, when applying NEDA-3 criteria to define active versus stable disease, individuals with active disease had significantly elevated CD4+ and CD8+ EVs compared to stable disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In summary, the analysis of specific immune cell-derived EV subsets may provide a method to monitor disability accumulation, disease activity, and axonal injury in MS, while also providing insights into the pathophysiology and cellular\/molecular mechanisms that influence progression.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cei\/uxaf003","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:31:06Z","timestamp":1736616666000},"source":"Crossref","is-referenced-by-count":4,"title":["Investigating T-cell-derived extracellular vesicles as biomarkers of disease activity, axonal injury, and disability in multiple sclerosis"],"prefix":"10.1093","volume":"219","author":[{"given":"Jennifer L","family":"Zagrodnik","sequence":"first","affiliation":[{"name":"Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie N","family":"Blandford","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neva J","family":"Fudge","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane T","family":"Arsenault","sequence":"additional","affiliation":[{"name":"Discipline of Medicine (Neurology), Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Anthony","sequence":"additional","affiliation":[{"name":"Discipline of Medicine (Neurology), Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"McGrath","sequence":"additional","affiliation":[{"name":"Discipline of Medicine (Neurology), Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Clift","sequence":"additional","affiliation":[{"name":"Discipline of Medicine (Neurology), Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stefanelli","sequence":"additional","affiliation":[{"name":"Discipline of Medicine (Neurology), Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3333-435X","authenticated-orcid":false,"given":"Craig S","family":"Moore","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]},{"name":"Discipline of Medicine (Neurology), Faculty of Medicine, Memorial University of Newfoundland , St. John\u2019s, NL ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"2025041017384846300_CIT0001","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","article-title":"Clinical presentation and diagnosis of multiple sclerosis","volume":"20","author":"Ford","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"2025041017384846300_CIT0002","doi-asserted-by":"publisher","first-page":"104630","DOI":"10.1016\/j.msard.2023.104630","article-title":"Cognitive impairment, fatigue and depression in multiple sclerosis: is there a difference between benign and non-benign MS","volume":"73","author":"Bogaardt","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"2025041017384846300_CIT0003","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7224\/1537-2073.2020-114","article-title":"Predicting long-term disability in multiple sclerosis: a narrative review of current evidence and future directions","volume":"24","author":"Weinstock-Guttman","year":"2022","journal-title":"Int J MS Care"},{"key":"2025041017384846300_CIT0004","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.3390\/ijms23115877","article-title":"Current and future biomarkers in multiple sclerosis","volume":"23","author":"Yang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025041017384846300_CIT0005","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12974-019-1674-2","article-title":"Molecular biomarkers in multiple sclerosis","volume":"16","author":"Ziemssen","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2025041017384846300_CIT0006","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"2025041017384846300_CIT0007","doi-asserted-by":"publisher","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","article-title":"Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"key":"2025041017384846300_CIT0008","doi-asserted-by":"publisher","first-page":"25729","DOI":"10.18632\/aging.203790","article-title":"Factors influencing serum neurofilament light chain levels in normal aging","volume":"13","author":"Koini","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"2025041017384846300_CIT0009","doi-asserted-by":"publisher","first-page":"11772719211053449","DOI":"10.1177\/11772719211053449","article-title":"Serum neurofilament light as a biomarker of traumatic brain injury in the presence of concomitant peripheral injury","volume":"16","author":"Wong","year":"2021","journal-title":"Biomark Insights"},{"key":"2025041017384846300_CIT0010","doi-asserted-by":"publisher","first-page":"e2457","DOI":"10.1212\/WNL.0000000000009571","article-title":"Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis","volume":"94","author":"Manouchehrinia","year":"2020","journal-title":"Neurology"},{"key":"2025041017384846300_CIT0011","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","article-title":"Neurofilament light chain elevation and disability progression in multiple sclerosis","volume":"80","author":"Abdelhak","year":"2023","journal-title":"JAMA Neurol"},{"key":"2025041017384846300_CIT0012","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol"},{"key":"2025041017384846300_CIT0013","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025041017384846300_CIT0014","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"key":"2025041017384846300_CIT0015","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/cells9071601","article-title":"Extracellular vesicles as delivery vehicles of specific cellular cargo","volume":"9","author":"Mir","year":"2020","journal-title":"Cells"},{"key":"2025041017384846300_CIT0016","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1074\/mcp.M116.064725","article-title":"Tracing cellular origin of human exosomes using multiplex proximity extension assays","volume":"16","author":"Larssen","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"2025041017384846300_CIT0017","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/1352458520924590","article-title":"Synaptic and complement markers in extracellular vesicles in multiple sclerosis","volume":"27","author":"Bhargava","year":"2021","journal-title":"Mult Scler"},{"key":"2025041017384846300_CIT0018","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/cells8091058","article-title":"Altered levels of toll-like receptors in circulating extracellular vesicles in multiple sclerosis","volume":"8","author":"Bhargava","year":"2019","journal-title":"Cells"},{"key":"2025041017384846300_CIT0019","doi-asserted-by":"publisher","first-page":"803921","DOI":"10.3389\/fimmu.2022.803921","article-title":"Analysis of plasma using flow cytometry reveals increased immune cell-derived extracellular vesicles in untreated relapsing-remitting multiple sclerosis","volume":"13","author":"Blandford","year":"2022","journal-title":"Front Immunol"},{"key":"2025041017384846300_CIT0020","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/1352458516658559","article-title":"Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment","volume":"23","author":"Buhler","year":"2017","journal-title":"Mult Scler"},{"key":"2025041017384846300_CIT0021","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10072-017-3176-2","article-title":"Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients","volume":"39","author":"Dalla Costa","year":"2018","journal-title":"Neurol Sci"},{"key":"2025041017384846300_CIT0022","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/aian.AIAN_159_19","article-title":"No evidence of disease activity (NEDA) in multiple sclerosis - shifting the goal posts","volume":"22","author":"Pandit","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"2025041017384846300_CIT0023","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s40120-023-00549-7","article-title":"No evidence of disease activity (NEDA) as a clinical assessment tool for multiple sclerosis: clinician and patient perspectives [Narrative Review]","volume":"12","author":"Newsome","year":"2023","journal-title":"Neurol Ther"},{"key":"2025041017384846300_CIT0024","doi-asserted-by":"publisher","first-page":"578175","DOI":"10.1016\/j.jneuroim.2023.578175","article-title":"Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis","volume":"382","author":"Brune-Ingebretsen","year":"2023","journal-title":"J Neuroimmunol"},{"key":"2025041017384846300_CIT0025","doi-asserted-by":"crossref","first-page":"e1051","DOI":"10.1212\/NXI.0000000000001051","article-title":"Increased serum neurofilament light and thin ganglion cell-inner plexiform layer are additive risk factors for disease activity in early multiple sclerosis","volume":"8","author":"Lin","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025041017384846300_CIT0026","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2023.06.025","article-title":"Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in Multiple sclerosis","volume":"113","author":"Torres Iglesias","year":"2023","journal-title":"Brain Behav Immun"},{"key":"2025041017384846300_CIT0027","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"2025041017384846300_CIT0028","doi-asserted-by":"publisher","first-page":"10381","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci Rep"},{"key":"2025041017384846300_CIT0029","doi-asserted-by":"publisher","first-page":"15863","DOI":"10.1038\/s41598-022-20398-y","article-title":"Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters","volume":"12","author":"Hermesdorf","year":"2022","journal-title":"Sci Rep"},{"key":"2025041017384846300_CIT0030","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12883-021-02447-7","article-title":"The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design","volume":"21","author":"Oh","year":"2021","journal-title":"BMC Neurol"},{"key":"2025041017384846300_CIT0031","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3390\/ijms24010894","article-title":"Myelin basic protein in oligodendrocyte-derived extracellular vesicles as a diagnostic and prognostic biomarker in multiple sclerosis: a Pilot Study","volume":"24","author":"Agliardi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025041017384846300_CIT0032","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1352458517696597","article-title":"Multiple sclerosis: serum-derived exosomes express myelin proteins","volume":"24","author":"Galazka","year":"2018","journal-title":"Mult Scler"},{"key":"2025041017384846300_CIT0033","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms21124407","article-title":"Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation","volume":"21","author":"Banks","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025041017384846300_CIT0034","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1073\/pnas.1816911116","article-title":"Extracellular vesicle fibrinogen induces encephalitogenic CD8+ T cells in a mouse model of multiple sclerosis","volume":"116","author":"Willis","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025041017384846300_CIT0035","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2202-15-110","article-title":"Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function","volume":"15","author":"Marcos-Ramiro","year":"2014","journal-title":"BMC Neurosci"},{"key":"2025041017384846300_CIT0036","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12987-021-00299-4","article-title":"CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis","volume":"19","author":"Mazzucco","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"2025041017384846300_CIT0037","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12964-023-01308-9","article-title":"Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles","volume":"21","author":"Brahmer","year":"2023","journal-title":"Cell Commun Signal"},{"key":"2025041017384846300_CIT0038","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1038\/s41598-022-05772-0","article-title":"Extracellular vesicle neurofilament light is elevated within the first 12-months following traumatic brain injury in a U.S military population","volume":"12","author":"Guedes","year":"2022","journal-title":"Sci Rep"},{"key":"2025041017384846300_CIT0039","doi-asserted-by":"publisher","first-page":"1756286420975917","DOI":"10.1177\/1756286420975917","article-title":"Neurofilament light chain level in plasma extracellular vesicles and Parkinson\u2019s disease","volume":"13","author":"Chung","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"2025041017384846300_CIT0040","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fncel.2018.00418","article-title":"Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: a study of the composition of extracellular vesicles in cerebrospinal fluid","volume":"12","author":"Geraci","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"2025041017384846300_CIT0041","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1096\/fj.201802319R","article-title":"Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury","volume":"33","author":"Goetzl","year":"2019","journal-title":"FASEB J"},{"key":"2025041017384846300_CIT0042","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1096\/fj.201902842R","article-title":"Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins","volume":"34","author":"Goetzl","year":"2020","journal-title":"FASEB J"},{"key":"2025041017384846300_CIT0043","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/intimm\/dxp011","article-title":"T-cell responses to neurofilament light protein are part of the normal immune repertoire","volume":"21","author":"Huizinga","year":"2009","journal-title":"Int Immunol"},{"key":"2025041017384846300_CIT0044","doi-asserted-by":"publisher","first-page":"1801153","DOI":"10.1080\/20013078.2020.1801153","article-title":"(Sub)populations of extracellular vesicles released by TNF-alpha -triggered human endothelial cells promote vascular inflammation and monocyte migration","volume":"9","author":"Hosseinkhani","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"2025041017384846300_CIT0045","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.actbio.2020.12.046","article-title":"Exosomes from TNF-\u03b1-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss","volume":"122","author":"Nakao","year":"2021","journal-title":"Acta Biomater"},{"key":"2025041017384846300_CIT0046","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ebiom.2018.02.003","article-title":"Neutrophil microvesicles from healthy control and rheumatoid arthritis patients prevent the inflammatory activation of macrophages","volume":"29","author":"Rhys","year":"2018","journal-title":"EBioMedicine"},{"key":"2025041017384846300_CIT0047","doi-asserted-by":"publisher","first-page":"e209357","DOI":"10.1212\/WNL.0000000000209357","article-title":"Temporal relationship between serum neurofilament light chain and radiologic disease activity in patients with multiple sclerosis","volume":"102","author":"Fox","year":"2024","journal-title":"Neurology"},{"key":"2025041017384846300_CIT0048","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.3390\/ijms19082448","article-title":"The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients","volume":"19","author":"Saenz-Cuesta","year":"2018","journal-title":"Int J Mol Sci"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxaf003\/61414996\/uxaf003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf003\/61414996\/uxaf003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf003\/61414996\/uxaf003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T17:39:02Z","timestamp":1744306742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxaf003\/7951877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxaf003","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"uxaf003"}}